Latest news with #Niva
NZ Autocar
23-06-2025
- Automotive
- NZ Autocar
Lada shows off first new model in 10 years and it looks okay
The Azimut is the Russian brand Lada's first new SUV design since the late 1990s. It is also the first new model launch from the brand since 2015, although under the skin it uses car mechanicals. For Kiwi Lada fans, expect to see none of them here any time soon because of sanctions related to Russia's invasion of Ukraine. Azimut is the first Lada SUV since the second-generation Niva launched in 1998. It is only the third production SUV in the company's history. Despite its contemporary appearance, beneath the sheetmetal is the running gear of the Lada Vesta small car. And that was Lada's last new release, debuting 10 years ago. The Azimut is 4416mm long and rides on a 2675mm wheelbase so it is similar in size to a Corolla Cross. It takes after the 2018 Lada Vision concept, featuring the same high bonnet and lateral belt lines. Lada Vision Concept But it looks modern with its slim LED lighting signatures. A black roof with a silver D-pillar matches the silver trim on the sills and bumpers. It will be available with two naturally-aspirated four-cylinder petrol engines, outputting 89 and 98kW from 1.6 and 1.8-litre displacements, respectively. Transmission options are a six-speed manual or CVT. A 1.5T engine from an outside unspecified source (likely to be Chinese) will join the range later. Azimut will be front-wheel drive only, with no plans for an all-wheel drive version. The interior includes a six-speaker stereo, keyless entry, and a reversing camera. Safety items include ABS brakes, stability control, and two airbags. Other safety or convenience items are reserved for higher level models or are cost options. Production is set for next year.
Time of India
23-04-2025
- Business
- Time of India
Niva Bupa shares rally over 11% as Motilal Oswal initiates coverage with 29% upside potential
Shares of Niva Bupa Health Insurance Company , which recently debuted on the bourses, surged as high as 11.5% to an intraday high of Rs 86.40 on the BSE after domestic brokerage firm Motilal Oswal initiated coverage on the stock, foreseeing an upside potential of 29%. Motilal Oswal has initiated the coverage with a 'buy' rating and a target price of Rs 100. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Get rid of age spots with two simple ingredients Tips and Tricks Undo 'We believe Niva has a strong position to harness the growth opportunity in the health insurance industry, backed by product innovation and customer base expansion. Investments in technology will give results in terms of operational efficiency and better profitability,' Motilal Oswal said in its report. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. The brokerage firm noted that Niva Bupa has emerged as one of the fastest-growing health insurers, delivering a CAGR of 34% during FY22- 25 and garnering the highest incremental market share in the retail health segment. The analysts at Motilal Oswal expect this growth momentum to stay strong and estimate a CAGR of 25% in gross written premium (GWP) over FY25-28E (Pre 1/n). Live Events Niva has a diversified product mix, with retail/group health accounting for 68%/31% as of 9MFY25. In the group segment, a one-third contribution comes from corporates and the remaining from credit-linked products. Consistent innovations and right pricing will boost momentum in its retail health segment. Additionally, Niva has undertaken a digital transformation aimed at elevating the customer experience across key touchpoints such as policy management, claims tracking, and telemedicine. These efforts are expected to strengthen the company's market reach, appeal to tech-savvy consumers, lower operational costs, and enhance overall service delivery. Also read: ICICI Bank dethrones HDFC Bank on every financial metric. A power shift underway in Indian banking? Niva operates through a well-diversified distribution model, with agents, corporate agents, brokers, and direct channels contributing 30%, 28%, 29%, and 13% respectively to its overall mix in 9MFY25. The company boasts one of the highest agent productivity levels in the industry, while its strong partnerships with brokers, banks, and web aggregators have effectively helped de-risk its distribution base. Further, Niva benefits from the leadership of an experienced management team and the strategic backing of global health giant Bupa. This alliance brings underwriting expertise, deep insurance industry experience, and robust distribution capabilities, all of which enhance Niva's financial resilience and long-term growth potential, the domestic brokerage firm noted. Motilal Oswal also stated that it expects the company to report a CAGR of 25% and 32% in pre-1/n GWP and PAT respectively over FY25-28.
Economic Times
23-04-2025
- Business
- Economic Times
Niva Bupa shares rally over 11% as Motilal Oswal initiates coverage with 29% upside potential
Shares of Niva Bupa Health Insurance Company, which recently debuted on the bourses, surged as high as 11.5% to an intraday high of Rs 86.40 on the BSE after domestic brokerage firm Motilal Oswal initiated coverage on the stock, foreseeing an upside potential of 29%. ADVERTISEMENT Motilal Oswal has initiated the coverage with a 'buy' rating and a target price of Rs 100. 'We believe Niva has a strong position to harness the growth opportunity in the health insurance industry, backed by product innovation and customer base expansion. Investments in technology will give results in terms of operational efficiency and better profitability,' Motilal Oswal said in its report. The brokerage firm noted that Niva Bupa has emerged as one of the fastest-growing health insurers, delivering a CAGR of 34% during FY22- 25 and garnering the highest incremental market share in the retail health analysts at Motilal Oswal expect this growth momentum to stay strong and estimate a CAGR of 25% in gross written premium (GWP) over FY25-28E (Pre 1/n).Niva has a diversified product mix, with retail/group health accounting for 68%/31% ADVERTISEMENT as of 9MFY25. In the group segment, a one-third contribution comes from corporatesand the remaining from credit-linked products. Consistent innovations and right ADVERTISEMENT pricing will boost momentum in its retail health Niva has undertaken a digital transformation aimed at elevating the customer experience across key touchpoints such as policy management, claims tracking, and telemedicine. These efforts are expected to strengthen the company's market reach, appeal to tech-savvy consumers, lower operational costs, and enhance overall service delivery. ADVERTISEMENT Also read: ICICI Bank dethrones HDFC Bank on every financial metric. A power shift underway in Indian banking?Niva operates through a well-diversified distribution model, with agents, corporate agents, brokers, and direct channels contributing 30%, 28%, 29%, and 13% respectively to its overall mix in 9MFY25. The company boasts one of the highest agent productivity levels in the industry, while its strong partnerships with brokers, banks, and web aggregators have effectively helped de-risk its distribution base. ADVERTISEMENT Further, Niva benefits from the leadership of an experienced management team and the strategic backing of global health giant alliance brings underwriting expertise, deep insurance industry experience, and robust distribution capabilities, all of which enhance Niva's financial resilience and long-term growth potential, the domestic brokerage firm Oswal also stated that it expects the company to report a CAGR of 25% and 32% in pre-1/n GWP and PAT respectively over FY25-28. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
